Q3 sales were pushed by the Chemtura acquisition and clearly rose +25% (p: +6%; v: +3%; FX: -3%; portfolio) to €2,404m. The gross profit margin softened from 32.2% to 22.9%, but EBITDA strongly improved by +31% to €315m. Net profit attributable to shareholders came to €55m after €62m. Operating CF rose +21% to €369m driven by higher D/A (€184m after €119m) and higher NWC inflow (€133m after €113m). Despite higher capex (€-125m after €-106
15 Nov 2017
Gross profit margin dampened
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Gross profit margin dampened
LANXESS AG (LXS:WBO) | 0 0 (-0.2%) | Mkt Cap: 6,194m
- Published:
15 Nov 2017 -
Author:
Martin Schnee -
Pages:
3
Q3 sales were pushed by the Chemtura acquisition and clearly rose +25% (p: +6%; v: +3%; FX: -3%; portfolio) to €2,404m. The gross profit margin softened from 32.2% to 22.9%, but EBITDA strongly improved by +31% to €315m. Net profit attributable to shareholders came to €55m after €62m. Operating CF rose +21% to €369m driven by higher D/A (€184m after €119m) and higher NWC inflow (€133m after €113m). Despite higher capex (€-125m after €-106